Ernexa Therapeutics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $0.00.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $10.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for the quarter ending 2015-12-31 was -$6.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $10.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $1.00K, a 97.73% decline from fiscal 2014.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $44.00K, a 4300.00% increase from fiscal 2013.
- Ernexa Therapeutics Inc. stock issued during period, value, stock options exercised for fiscal 2013 was $1.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $10.00K 10-K · filed 2023-03-20 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $10.00K 10-Q · filed 2022-08-11 | |
| 2015-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2015-06-30 | $3.00K 10-Q · filed 2016-08-04 | |
| 2014-12-31 | $44.00K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $1.00K 10-K · filed 2015-03-27 | |
| 2011-12-31 | $36.00K 10-K · filed 2013-03-29 | |
| 2010-12-31 | $61.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |